While doing our research, we’ve noted a lot of company press releases that seem impressive on the surface, but that have all ultimately led to where the company is now-poised for more dilution and continually posting losses. When considering whether […]
Summary A number of factors lead us to the conclusion that 22nd Century Group (XXII) is severely overvalued and likely worth no more than $0.20 per share. In the past, the SEC charged XXII CEO Joseph Pandolfino, Jr. for stock […]
Summary Cannabidiol (“CBD”), a cannabis-based substance, is the focus of INSY and GWPH, two companies competing to develop CBD for the treatment of Dravet Syndrome, a form of childhood epilepsy. Contrary to what appears to be respected analysts’ expectations, INSY […]
Call(s) to Action: This morning we stated: GeoBargain on the radar CRTN (old symbol TMNG)($4.16) – Appears the company has come through with a breakout quarter. We have been waiting for a quarter like this since the company embarked on […]
Call(s) to Action: QLTY ($13.28) – In our 8/4/2014 email we stated: “Will nibble at shares prior to Q2 2014 earnings which are expected to be announced tomorrow after the close.” Q2 2014 revenues and EPS were generally in line […]
Call(s) to Action: EXETF ($6.81) – We are adding to our position. Recent price action strength coupled with the company’s ability to refinance its debt leads us to believe a resolution is nearing in the company’s strategic review. EXETF has […]
Call(s) to Action: None Here are the stories that the GeoTeam is following today… (Please see full disclosures at bottom) ChinaHybrids BOPH ($1.55) – Products picked up by nearly 4,000 new Chinese medical facilities in six month span. CXDC ($7.65; […]
Call(s) to Action: Coding IIN and ICCC as GeoBargain on the radars; will look to nibble at shares and look to interview management to confirm our optimism. ICCC ($4.65) – Coding as a GBR based on strong Q1 2014 results, […]